Literature DB >> 8405697

Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice.

A G Baxter1, A Cooke.   

Abstract

The NOD mouse is widely used as a model of organ-specific autoimmunity because it develops specific autoimmune destruction of pancreatic beta-cells. Although it is clear that T-cells and monocytes are necessary for beta-cell destruction, humoral factors, such as antibodies and complement, may also contribute to tissue damage. Attempts to cure diabetes in experimental models by immunoisolation of transplanted islets has raised the need to protect the islets from the relatively small components of the complement cascade. In this study, we report that NOD mice have no complement lytic activity and that the exclusion of complement is unnecessary in this model. Sera from young NOD mice were unable to lyse sheep red blood cells coated with rabbit antibody. Lytic activity of NOD sera was reconstituted by mixing with C4-deficient CBA sera, but not C5-deficient DBA/2 sera, indicating the presence of C4, but the absence of C5 activity in NOD sera. Lytic activity of NOD sera could be reconstituted with human C5 electrofocused in polyacrylamide gel. The polymerase chain reaction was used to amplify fragments from genomic DNA corresponding to the region of Hc (the gene encoding C5) in DBA/2 mice, which carries a 2-base pair deletion responsible for the lack of C5 protein expression in these mice. DBA/2 and NOD mice from several colonies produced a fragment 2 bases shorter than that generated from the wild-type allele in BALB/c mice.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405697     DOI: 10.2337/diab.42.11.1574

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  45 in total

1.  BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.

Authors:  Kerry J Lavender; Wendy W Pang; Ronald J Messer; Amanda K Duley; Brent Race; Katie Phillips; Dana Scott; Karin E Peterson; Charles K Chan; Ulf Dittmer; Timothy Dudek; Todd M Allen; Irving L Weissman; Kim J Hasenkrug
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

2.  Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.

Authors:  Cuong Q Nguyen; Hyuna Kim; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Perforin-independent rejection of transplanted human stem cells.

Authors:  S Kaiser; D Kägi; G Ihorst; U Kapp
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.

Authors:  V Menard; H Jacobs; H S Jun; J W Yoon; S W Kim
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 5.  Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.

Authors:  John P Driver; Yi-Guang Chen; Clayton E Mathews
Journal:  Rev Diabet Stud       Date:  2012-12-28

6.  Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

Authors:  Chunyan Yang; Fangfang Chen; Ping Ren; Laren Lofchy; Chun Wan; Jingshi Shen; Guankui Wang; Hanmant Gaikwad; Jessica Ponder; Craig T Jordan; Robert Scheinman; Dmitri Simberg
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

7.  Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin.

Authors:  Marvin Lin; Na Yin; Barbara Murphy; M Edward Medof; Stephan Segerer; Peter S Heeger; Bernd Schröppel
Journal:  Diabetes       Date:  2010-06-28       Impact factor: 9.461

8.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.

Authors:  D L Greiner; L D Shultz; J Yates; M C Appel; G Perdrizet; R M Hesselton; I Schweitzer; W G Beamer; K L Shultz; S C Pelsue
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 9.  The role of the complement system in metabolic organs and metabolic diseases.

Authors:  Julia Phieler; Ruben Garcia-Martin; John D Lambris; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

Review 10.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.